(EN) Patent 543655 Provided is the use of a composition comprising a therapeutically effective amount of an inhibitor of a SARS-associated tumor necrosis factor (TNF) cytokine in a pharmaceutically acceptable carrier for the manufacture of a medicament for treating Severe Acute Respiratory Syndrome (SARS). Further provided is the use of similar compositions additionally comprising an anti-coronaviral compound and methods of screening said inhibitors in non-human animals.